Smith Group Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Smith Group Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-74,770	Closed	-$632K	–	519
2015 Q3	$632K	Sell	74,770 -806	-1%	-$7.43K	0.02%	186
2015 Q2	$828K	Sell	75,576 -7,740	-9%	-$99.3K	0.03%	179
2015 Q1	$1.17M	Buy	83,316 +4,526	+6%	+$69.2K	0.04%	170
2014 Q4	$1.33M	Buy	+78,790	New	+$1.15M	0.05%	164

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Smith Group Asset Management's INFI Position: Q4 2015 in Review

Smith Group Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 74,770 shares — an estimated $632K sold.

Smith Group Asset Management first reported a position in INFI in Q4 2014 and held it in 4 quarters. The position peaked at $1.33M in Q4 2014. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

Smith Group Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Smith Group Asset Management sold 74,770 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $632K.
Smith Group Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
Smith Group Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1.33M in Q4 2014.
115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.